Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Disease × CA-125 Antigen × Gynecologic × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 3 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Uterine Cervical Neoplasms 1 Sarcoma 1 Neoplasm Invasiveness 1 Myofibroma 1 Hereditary Breast and Ovarian Cancer Syndrome 1 Fallopian Tube Neoplasms 1 Endometrial Neoplasms 1 Disease 1 Carcinoma, Ovarian Epithelial 1

Interventions

Blood Specimen Collection 3 pembrolizumab 1 atezolizumab 1 TKM-080301 1 TIC10 compound 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 RNA, Long Noncoding 1 Interviews as Topic 1 Interleukin-15 1 HIV Testing 1 Educational Status 1 Diffusion 1 CA-125 Antigen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02296307 2024-05-02

DOvEE

McGill University

13,600 enrolled

Disease, Neoplasm Invasiveness, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡